BioMarin Pharmaceutical
BMRN
#1932
Rank
NZ$18.07 B
Marketcap
NZ$93.98
Share price
1.08%
Change (1 day)
-7.59%
Change (1 year)

BioMarin Pharmaceutical (BMRN) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : NZ$2.55 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's total liabilities are NZ$2.55 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BioMarin Pharmaceutical - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31NZ$2.60 B10.26%
2024-12-31NZ$2.35 B-21.04%
2023-12-31NZ$2.98 B7.09%
2022-12-31NZ$2.79 B9.61%
2021-12-31NZ$2.54 B5.46%
2020-12-31NZ$2.41 B3.72%
2019-12-31NZ$2.32 B7%
2018-12-31NZ$2.17 B-15.32%
2017-12-31NZ$2.56 B41.52%
2016-12-31NZ$1.81 B-6.48%
2015-12-31NZ$1.94 B60.52%
2014-12-31NZ$1.20 B10.05%
2013-12-31NZ$1.09 B63.59%
2012-12-31NZ$0.67 B-1.58%
2011-12-31NZ$0.68 B-3.45%
2010-12-31NZ$0.70 B-13.7%
2009-12-31NZ$0.81 B-24.55%
2008-12-31NZ$1.08 B32.51%
2007-12-31NZ$0.81 B66.99%
2006-12-31NZ$0.49 B22.94%
2005-12-31NZ$0.39 B-5.38%
2004-12-31NZ$0.42 B97.97%
2003-12-31NZ$0.21 B823.51%
2002-12-31NZ$23.06 M-21.88%
2001-12-31NZ$29.53 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Sanofi
SNY
NZ$109.65 B 4,194.68%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
NZ$2.71 B 6.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
NZ$0.13 B-94.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ$1.38 B-45.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$1.14 B-55.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
NZ$0.25 B-90.07%๐Ÿ‡บ๐Ÿ‡ธ USA